DE3627759A1 - Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine - Google Patents

Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine

Info

Publication number
DE3627759A1
DE3627759A1 DE19863627759 DE3627759A DE3627759A1 DE 3627759 A1 DE3627759 A1 DE 3627759A1 DE 19863627759 DE19863627759 DE 19863627759 DE 3627759 A DE3627759 A DE 3627759A DE 3627759 A1 DE3627759 A1 DE 3627759A1
Authority
DE
Germany
Prior art keywords
composition according
peroxydiphosphate
compound
endotoxin
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19863627759
Other languages
German (de)
English (en)
Inventor
Abdul Gaffar
Edward J Coleman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colgate Palmolive Co
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of DE3627759A1 publication Critical patent/DE3627759A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19863627759 1985-08-22 1986-08-16 Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine Ceased DE3627759A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76839685A 1985-08-22 1985-08-22
US85191586A 1986-04-14 1986-04-14

Publications (1)

Publication Number Publication Date
DE3627759A1 true DE3627759A1 (de) 1987-03-19

Family

ID=27118049

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19863627759 Ceased DE3627759A1 (de) 1985-08-22 1986-08-16 Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine

Country Status (12)

Country Link
BE (1) BE905319A (cs)
CA (1) CA1282004C (cs)
CH (1) CH670046A5 (cs)
DE (1) DE3627759A1 (cs)
DK (1) DK168513B1 (cs)
FR (1) FR2586351B1 (cs)
GB (1) GB2180451B (cs)
HK (1) HK593A (cs)
IT (1) IT1196587B (cs)
NL (1) NL8602140A (cs)
SE (1) SE468626B (cs)
SG (1) SG108892G (cs)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628190A1 (de) * 1985-08-22 1987-02-26 Colgate Palmolive Co Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20024880L (no) * 2002-03-19 2003-09-22 Per Hamre Sammensetning inneholdende fosfat

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
DE3523263A1 (de) * 1984-06-27 1986-01-09 Colgate-Palmolive Co., New York, N.Y. Arzneimittel
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
DE3523263A1 (de) * 1984-06-27 1986-01-09 Colgate-Palmolive Co., New York, N.Y. Arzneimittel
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3628190A1 (de) * 1985-08-22 1987-02-26 Colgate Palmolive Co Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen

Also Published As

Publication number Publication date
GB8620482D0 (en) 1986-10-01
IT1196587B (it) 1988-11-16
NL8602140A (nl) 1987-03-16
SE8603486D0 (sv) 1986-08-19
BE905319A (fr) 1987-02-23
DK402086A (da) 1987-02-23
SG108892G (en) 1992-12-24
SE468626B (sv) 1993-02-22
FR2586351B1 (fr) 1991-10-18
DK402086D0 (da) 1986-08-22
SE8603486L (sv) 1987-02-23
CA1282004C (en) 1991-03-26
CH670046A5 (cs) 1989-05-12
GB2180451B (en) 1989-10-18
IT8648389A1 (it) 1988-02-19
DK168513B1 (da) 1994-04-11
FR2586351A1 (fr) 1987-02-27
IT8648389A0 (it) 1986-08-19
GB2180451A (en) 1987-04-01
HK593A (en) 1993-01-15

Similar Documents

Publication Publication Date Title
DE69932939T2 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE3907649C2 (de) Arzneimittel, geeignet bei der Bekämpfung von Viren und zur Immunstimulierung
DE69323185T2 (de) Proteinkinase c-inhibitor
CH660970A5 (de) Verfahren zur herstellung antibakterieller methylol-transfer-mittel.
DE2822789C2 (de) N-Acetyl-DL-methionin-(p-acetylaminophenyl)-ester, Verfahren zu seiner Herstellung und seine Verwendung
DE69512929T2 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
DE3782686T2 (de) Zusammensetzungen zur vorbeugung von plastik-abstossung.
DE3448155C2 (cs)
DE69006046T2 (de) Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen.
EP0170099B1 (de) Verwendung von Lycorin als Immunsuppressor
DE3907688C2 (de) Salze von ungesättigten Fettsäuren mit Aminosäuren, Verfahren zu ihrer Herstellung sowie die Verwendung der ersteren und von weiteren derartigen Salzen
EP0374096A1 (de) 2',3'-Dideoxypurinnucleosid/Purinnucleosid-Phosphorylase-Inhibitor Kombinationstherapie und Zusammensetzungen dafür
DE2048375A1 (de) Wirksammachung von Antibiotika
DE3627759A1 (de) Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
CH621333A5 (cs)
DE69003670T2 (de) Nicht einspritzbares karzinostatisches mittel zur vorbeugung der entzündung durch 5-fluoruracil und verfahren zur behandlung von krebs.
DE2820794C2 (de) Salze der (-Hcis)-l^-Epoxypropylphosphonsäure, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Präparat
AT392002B (de) Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
DE2625835A1 (de) Arzneimittel auf basis von adenosin-5'-thioaethern
EP0152860B1 (de) Verwendung von Cephemverbindungen zur Herstellung eines Arzneimittels für die Modulation des Immunsystems
DE3414049C2 (cs)
DE3628190A1 (de) Pharmazeutische zusammensetzung zur behandlung von parathyreoid-hormon induzierter knochenresorption
DE1068701B (de) Verfahren zur Herstellung von antibiotisch wirksamem Tetracyclinnatriumhexametaphosphat
DE4435525C2 (de) Präparat zur Behandlung von Entmarkungsenzephalitiden
DE2844534C2 (cs)

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: STOLBERG-WERNIGERODE, GRAF ZU, U., DIPL.-CHEM. DR.

8110 Request for examination paragraph 44
8131 Rejection